Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
150.7 DKK | +1.23% | +0.13% | -15.30% |
Mar. 13 | Swiss Regulator Clears Bavarian Nordic’s Jynneos for Smallpox Immunization in Adults | MT |
Mar. 13 | Bavarian Nordic A/S Receives Approval of Smallpox and Mpox Vaccine in Switzerland | CI |
Evolution of the average Target Price on Bavarian Nordic A/S
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- BAVA Stock
- Consensus Bavarian Nordic A/S